[Fund Index | Funds By Family | Fund Top Performers]

Mutual Fund Top Performers - Mid-Cap Value

As of 30-Sep-09

Select a symbol for a detailed quote and links to additional information.

Top Performers - 3 Month (out of 435) Fund Name Symbol Return Touchstone JSAM Institutional Value CIJVX 47.66% Rydex S&P MidCap 400 Pure Value H RYAVX 36.60% Rydex S&P MidCap 400 Pure Value A RYMVX 36.59% Rydex S&P MidCap 400 Pure Value C RYMMX 36.27% Flex-funds Quantex FLCGX 32.79% Hotchkis and Wiley Value Opps Instl HWAIX 29.57% Hotchkis and Wiley Value Opps A HWAAX 29.52% Hotchkis and Wiley Value Opps C HWACX 29.22% Hotchkis and Wiley Mid-Cap Value I HWMIX 28.63% Hotchkis and Wiley Mid-Cap Value A HWMAX 28.51%
Top Performers - 1 Year (out of 417) Fund Name Symbol Return Appleseed APPLX 25.46% Hotchkis and Wiley Value Opps Instl HWAIX 21.50% Hotchkis and Wiley Value Opps A HWAAX 21.31% Hotchkis and Wiley Value Opps C HWACX 20.85% ING Value Choice W IVCWX 19.43% ING Value Choice I PAVIX 19.31% ING Value Choice A PAVAX 19.06% ING Value Choice O PAVOX 19.05% ING Value Choice C PAVCX 18.15% ING Value Choice B PAVBX 18.13%		Top Performers - 3 Year (out of 338) Fund Name Symbol Ann. Ret. ING Value Choice I PAVIX 5.07% ING Value Choice W IVCWX 4.96% ING Value Choice A PAVAX 4.79% ING Value Choice O PAVOX 4.77% ING Value Choice C PAVCX 4.00% ING Value Choice B PAVBX 4.00% Nicholas Equity Income I NSEIX 2.71% Janus Aspen Perkins Mid Cap Value Instl JAMVX 2.36% Perkins Mid Cap Value L JMIVX 2.04% Perkins Mid Cap Value I JMVAX 2.03%
Top Performers - 5 Year (out of 248) Fund Name Symbol Ann. Ret. Rydex/SGI Mid Cap Value A SEVAX 8.52% Rydex/SGI Mid Cap Value Inst SVUIX 8.26% Rydex/SGI Mid Cap Value B SVSBX 7.72% Rydex/SGI Mid Cap Value C SEVSX 7.72% RidgeWorth Mid-Cap Value Equity I SMVTX 7.40% RidgeWorth Mid-Cap Value Equity A SAMVX 7.08% Artisan Mid Cap Value ARTQX 7.00% Janus Aspen Perkins Mid Cap Value Instl JAMVX 6.94% Victory Established Value A VETAX 6.91% Victory Established Value R GETGX 6.77%

Get Morningstar's portfolio tools, data, and editorial insights, plus Analyst Reports on 1,450 stocks and 2,000 funds. Start your free 14-day trial today.